Forte Biosciences, Inc.
Pharmaceutical company · Dallas, Texas, United States · Nasdaq: FBRX
Forte Biosciences, Inc. is a pharmaceutical company headquartered in Dallas, Texas, United States. Its earliest recorded incorporation is in 2007. Its shares trade on Nasdaq under the ticker FBRX. It has reported private securities offerings to the US SEC, most recently $25 million sold in a notice filed in 2023.
Forte Biosciences at a glance
What does Forte Biosciences do?
Private fundraising reported to the SEC
21 Form D notices; the most recent reported $25 million sold (2023).
Frequently asked questions about Forte Biosciences
Where is Forte Biosciences headquartered?
Forte Biosciences, Inc. is headquartered in Dallas, Texas, United States.
What does Forte Biosciences do?
Forte Biosciences, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Forte Biosciences a public company?
Yes. Forte Biosciences, Inc. trades on Nasdaq under the ticker FBRX.
When was Forte Biosciences founded?
The earliest incorporation on record for Forte Biosciences, Inc. is in 2007, according to public company registers.
Similar companies
- Lantern Pharma Inc.Dallas, Texas, United States
- CerSci Therapeutics Inc.Dallas, Texas, United States
- Hyperion Defi, Inc.Dallas, Texas, United States
- Osteal Therapeutics, Inc.Dallas, Texas, United States
- Arog Pharmaceuticals, Inc.Dallas, Texas, United States
- Pharmabiotix IncDallas, Texas, United States
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-24. Data licences